CA Healthcare Acquisition Corp (CAHC) to Combine with LumiraDx in $5Bn Deal

CA Healthcare Acquisition Corp (CAHC) to Combine with LumiraDx in $5Bn Deal

CA Healthcare (NASDAQ:CAHC) has entered into a definitive agreement to combine with medical device-maker LumiraDx at an enterprise value of $5 billion, or 26.6x its 2020 revenue. LumiraDx has developed a pair of diagnostic systems designed to decentralize testing for a range of conditions including COVID-19. The combined company is expected to trade on the
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.